University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Diagnostic Accuracy of HPV16 Early Antigen Serology For HPV-Driven Oropharyngeal Cancer is Independent of Age and Sex

Simple item page
dc.contributor.authorKusters, Johannes MA
dc.contributor.authorDiergaarde, Brenda
dc.contributor.authorNess, Andrew R.
dc.contributor.authorvan der Loef, Maarten F Schim
dc.contributor.authorHeijne, Janneke CM
dc.contributor.authorSchroeder, Lea
dc.contributor.authorHueniken, Katrina
dc.contributor.authorMckay, James D.
dc.contributor.authorMacfarlane, Gary
dc.contributor.authorLagiou, Pagona
dc.contributor.authorLagiou, Areti
dc.contributor.authorPolesel, Jerry
dc.contributor.authorAgudo, Antonio
dc.contributor.authorAlemany, Laia
dc.contributor.authorAhrens, Wolfgang
dc.contributor.authorHealy, Claire M
dc.contributor.authorConway, David I
dc.contributor.authorRobinson, Max
dc.contributor.authorCanova, Christina
dc.contributor.authorHolcátová, Ivana
dc.contributor.authorRichiardi, Lorenzo
dc.contributor.authorZnaor, Ariana
dc.contributor.authorPring, Miranda
dc.contributor.authorThomas, Steve
dc.contributor.authorHayes, Neil
dc.contributor.authorLiu, Geoffrey
dc.contributor.authorHung, Rayjean J.
dc.contributor.authorBrennan, Paul
dc.contributor.authorOlshan, Andrew F
dc.contributor.authorVirani, Shama
dc.contributor.authorWaterboer, Tim
dc.contributor.institutionUniversity of Aberdeen.Vice Principalsen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2023-09-11T13:38:01Z
dc.date.available2023-09-11T13:38:01Z
dc.date.issued2024-01-15
dc.descriptionFunding information: This project was funded in part by NIH/NIDCR R01 DE025712 (Paul Brennan, Brenda Diergaarde and Neil Hayes). The Alcohol-Related Cancers and Genetic Susceptibility Study in Europe (ARCAGE) was funded by the European Commission’s fifth framework program (QLK1-2001-00182), the Italian Association for Cancer Research, Compagnia di San Paolo/FIRMS, Region Piemonte and Padova University (CPDA057222). We thank Dr. Wolfgang Ahrens, PhD (Universität Bremen, Germany) for his support in ARCAGE study. The Carolina Head and Neck Cancer Epidemiology (CHANCE) study was supported in part by the National Cancer Institute (R01-CA90731). The Head and Neck 5000 study was a component of independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0707-10034). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Core funding was also provided through awards from Above and Beyond, University Hospitals Bristol and Weston Research Capability Funding and the NIHR Senior Investigator award to Professor Andy Ness. Human papillomavirus (HPV) serology was supported by a Cancer Research UK Programme Grant, the Integrative Cancer Epidemiology Programme (grant number: C18281/A19169). The University of Pittsburgh head and neck cancer case-control study is supported by US National Institutes of Health grants P50CA097190 and P30CA047904. The MSH-PMH study was supported by Canadian Cancer Society Research Institute and Lusi Wong Programs at the Princess Margaret Hospital Foundation.en
dc.description.statusPeer revieweden
dc.format.extent13
dc.format.extent1844087
dc.identifier271577432
dc.identifier63583ffd-a163-424e-aca0-7423876ba0ab
dc.identifier37694289
dc.identifier85170574338
dc.identifier.citationKusters, J MA, Diergaarde, B, Ness, A R, van der Loef, M F S, Heijne, J CM, Schroeder, L, Hueniken, K, Mckay, J D, Macfarlane, G, Lagiou, P, Lagiou, A, Polesel, J, Agudo, A, Alemany, L, Ahrens, W, Healy, C M, Conway, D I, Robinson, M, Canova, C, Holcátová, I, Richiardi, L, Znaor, A, Pring, M, Thomas, S, Hayes, N, Liu, G, Hung, R J, Brennan, P, Olshan, A F, Virani, S & Waterboer, T 2024, 'Diagnostic Accuracy of HPV16 Early Antigen Serology For HPV-Driven Oropharyngeal Cancer is Independent of Age and Sex', International Journal of Cancer, vol. 154, no. 2, pp. 289-402. https://doi.org/10.1002/ijc.34710en
dc.identifier.doi10.1002/ijc.34710
dc.identifier.iss2en
dc.identifier.issn0020-7136
dc.identifier.otherORCID: /0000-0003-2322-3314/work/142142901
dc.identifier.urihttps://hdl.handle.net/2164/21637
dc.identifier.vol154en
dc.language.isoeng
dc.relation.ispartofInternational Journal of Canceren
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectHuman papillomavirusen
dc.subjectoropharyngeal canceren
dc.subjecthead and neck canceren
dc.subjectserologyen
dc.subjectdiagnostic accuracyen
dc.subjectR Medicineen
dc.subjectCancer Research UKen
dc.subjectC18281/A19169en
dc.subjectEuropean Commissionen
dc.subjectQLK1-2001-00182en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectRP-PG-0707-10034en
dc.subject.lccRen
dc.titleDiagnostic Accuracy of HPV16 Early Antigen Serology For HPV-Driven Oropharyngeal Cancer is Independent of Age and Sexen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kusters_etal_IJC_Diagnostic_Accuracy_Of_VoR.pdf
Size:
1.76 MB
Format:
Adobe Portable Document Format
Download

Collections

All research